Zhengye Biotechnology Holding Ltd SEC filings ZYBT

Zhengye Biotechnology Holding Ltd has 61 filings in SEC EDGAR's recent list, going back to Aug 4, 2023. Its latest annual report, Form 20-F, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Aug 6, 2026.

Form Description Filed Period
3 Initial insider ownership Jun 25, 2026 Jun 25, 2026
3 Initial insider ownership Jun 25, 2026 Jun 25, 2026
3 Initial insider ownership Jun 25, 2026 Jun 25, 2026
3 Initial insider ownership Jun 25, 2026 Jun 25, 2026
3 Initial insider ownership Jun 25, 2026 Jun 25, 2026
3 Initial insider ownership Apr 24, 2026 Mar 24, 2026
3 Initial insider ownership Apr 24, 2026 Mar 24, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
3 Initial insider ownership Mar 18, 2026 Mar 18, 2026
144 Notice of proposed sale Oct 22, 2025 —
144 Notice of proposed sale Oct 22, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Feb 21, 2025 —

Showing 14 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ZYBT (Nasdaq)
Incorporated in
China
Headquarters
Jilin
SEC filer status
Non-accelerated filer, Emerging growth company
SEC CIK
1975641

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.